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When cells become committed to apoptosis, they shatter
their mitochondrial networks through the actions of the
mitochondrial ﬁssion protein DRP1. Massive fragmentation
of mitochondria facilitates simultaneous release of cyto-
chrome c from all mitochondria within a cell, thus promot-
ing further progression along the apoptotic pathway. In this
issue, Tondera et al (2009) describe a new process with the
opposite effect. When cells are subjected to modest levels of
stress (well below levels needed to induce apoptosis), their
mitochondria fuse to each other forming a closed network,
similar to networks observed when mitochondrial ﬁssion is
blocked. Stress-induced mitochondrial hyperfusion (SIMH),
as this process was called, might counter stress by optimiz-
ing mitochondrial ATP production.
Mitochondria of healthy cells continually divide and fuse
with each other (Okamoto and Shaw, 2005; Chan, 2006;
Hoppins et al, 2007). Mitochondrial ﬁssion facilitates the
redistribution of mitochondria in response to local changes
in the demand for ATP and it allows for disposal of faulty
mitochondrial fragments through mitophagy, whereas mito-
chondrial fusion promotes exchange of mtDNA and other vital
components, thus reinvigorating the mitochondrial network.
Mitochondrial ﬁssion and fusion processes are mediated by a
series of dynamin family members. Fission is mediated by the
dynamin-related protein DRP1. Mutations in the gene coding
for this protein give rise to a highly interconnected network of
mitochondria. Fusion is mediated by the dynamin-related
proteins MFN1 and MFN2 at the mitochondrial outer mem-
branes and the dynamin-related protein OPA1 at the mito-
chondrial inner membranes. Mutations in the genes coding for
these proteins give rise to fragmented mitochondria, because
ﬁssion still occurs while fusion is blocked. Mutations in the
genes coding for the mitochondrial fusion proteins are also
responsible for two human diseases. Patients with a hetero-
zygous mutation in MFN2 develop a peripheral neuropathy
called Charcot–Marie–Tooth disease (CMT-2A) and patients
with heterozygous mutations in OPA1 develop dominant optic
atrophy (DOA) through progressive loss of retinal ganglion
cells. The severity of heterozygous mutations in humans and
the lethality of homozygous mutations in mice show that
mitochondrial ﬁssion and fusion processes are crucially
important for cell survival (Chan, 2006; Davies et al, 2007).
The rates of mitochondrial ﬁssion and fusion vary between
cell types and different growth conditions, but they are usually
balanced within a cell. However, the rate of ﬁssion does
increase markedly without a compensating increase in the
rate of fusion when cells become committed to apoptosis
(Suen et al, 2008). Increased ﬁssion in apoptotic cells coincides
with the release of cytochrome c and mutations in the genes
for the ﬁssion protein DRP1 can delay the release of
cytochrome c, suggesting that apoptotic cytochrome c release
is intimately connected with mitochondrial ﬁssion. Tondera
et al (2009) now add a new twist to this plot with their
discovery of a pathway that they call Stress-induced mitochon-
drial hyperfusion (SIMH) pathway. They show that treatments
w i t hl o wl e v e l so ft o x i ca g e n t ss u c ha sc y c l o h e x i m i d e ,U V
irradiation or actinomycin D have the opposite effect of full-
blown apoptosis-inducing treatments. Instead of inducing mi-
tochondrial fragmentation as observed in apoptotic cells, these
treatments cause mitochondria to fuse into a closed network,
similar to networks observed in cells with mitochondrial ﬁssion
defects (Figure 1). This closed network confers some degree of
Figure 1 Mitochondrial ﬁssion and fusion cycles normally consist
of ﬁssion mediated by DRP1 and fusion mediated by MFN1, MFN2
and the short and long forms (S and L) of OPA1. Cells that are
committed to apoptosis (equated here with high levels of stress) use
DRP1-mediated ﬁssion to promote cytochrome c release. The newly
discovered SIMH pathway, which is induced by low levels of stress,
has the opposite effect, namely the formation of a closed mitochon-
dria network through the actions of MFN1 and L-OPA1, but not
MFN2 or S-OPA1, SIMH pathway confers resistance to further
stress, but eventually cells might succumb to apoptosis.
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ness of mitochondria through exchange of crucial components.
One might ask whether the SIMH pathway merely reﬂects
increased activity of the conventional fusion machinery or
alternatively represents a deliberate switch to an alternative
pathway. Tondera et al (2009) found three differences in protein
requirements, suggesting mechanistic differences between
SIMH pathway and conventional fusion. The ﬁrst difference
was observed with MFN1 and MFN2 knockout cells, which
normally have fragmented mitochondria. Fragmentation in both
cell types indicates that conventional mitochondrial fusion
depends on the combined actions of MFN1 and MFN2.
However, low levels of stress induce ﬁlamentous mitochondria
in MFN2 knockout cells but not in MFN1 knockout cells,
suggesting that SIMH pathway requires MFN1 but not MFN2
(Figure 1). Several years ago a speciﬁc requirement for MFN1
was noted when fusion was induced by the overexpression of
OPA1 (Cipolat et al, 2004). Could this inducible fusion have
been equivalent to SIMH? Conversely, MFN2 has not been
linked with inducible fusion under either condition, but it was
previously linked to Charcot–Marie–Tooth disease. The picture
that is starting to emerge is that of dual requirements for MFN1
and MFN2 under normal conditions and additional dedicated
functions of these proteins under special circumstances. MFN2
could, for example, affect axonal transport of mitochondria, as
suggested in the Charcot–Marie–Tooth disease, although MFN1
can mediate mitochondrial fusion without help from MFN2
when cells are subjected to low levels of stress.
The second difference was discovered with OPA1. In un-
stressed cells, certain isoforms of OPA1 are constitutively
cleaved by the mitochondrial intermembrane space AAA pro-
tease YME1L (Griparic et al, 2007; Song et al, 2007). This
cleavage removes the amino terminal transmembrane segment
to generate a short form of OPA1 (S-OPA1). Isoforms that are
not cleaved by YME1L retain their amino terminal transmem-
brane segment and are called the long form of OPA1 (L-OPA1).
Conventional fusion of mitochondrial inner membranes re-
quires the combined actions of S- and L-OPA1 (Song et al,
2007). Tondera et al (2009) now show that L-OPA1, but not
S-OPA1, is required for SIMH. A unique requirement for L-OPA1
is consistent with an earlier report in which it was shown that
YME1L siRNA, which leads to an accumulation of L-OPA1, also
leads to a fused mitochondrial network (Griparic et al, 2007).
The third difference was noted in the requirements for main-
taining intact OPA1. Under adverse conditions, OPA1 is proteo-
lytically inactivated by the actions of an as yet unknown
protease (Griparic et al, 2007). This proteolytic inactivation
occurs during apoptosis, but it also occurs when certain
scaffolding proteins called prohibitins are not around
(Merkwirth et al,2 0 0 8 ) .T o n d e r aet al (2009) now show that
SIMH requires a different scaffolding protein, the stomatin-like
protein SLP-2, to prevent proteolytic inactivation of OPA1. As
the requirements for MFN1 and MFN2 at the mitochondrial
outer membrane, the requirements for S- and L-OPA1 at the
mitochondrial inner membrane and the scaffolding proteins
required for maintaining the integrity of L-OPA1 are all differ-
ent, one can conclude that there are important differences
between SIMH pathway and conventional mitochondrial fu-
sion, consistent with an alternative pathway.
Until now, mitochondrial fusion seemed like a monolithic
problem begging for a biochemical solution. The discoveries of
Tondera et al (2009) add nuance to this problem. What are the
specialized functions of MFN1 and MFN2? Why does conven-
tional fusion require S- and L-OPA1, whereas SIMH only needs
L-OPA1? Why are different scaffolding proteins involved in
OPA1 function? In addition to these mechanistic questions,
there are also new questions about regulation. How do different
forms of cellular stress converge on the mitochondrial fusion
apparatus? Which protein modiﬁcations steer the fusion appa-
ratus towards the conventional fusion process and which ones
steer it towards SIMH? These types of questions will inevitably
c h a n g et h ec o u r s eo ff u t u r ee x p e r i m e n t s .
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